助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   acute aggravation period 的翻译结果: 查询用时:0.198秒
图标索引 在分类学科中查询
所有学科
中西医结合
呼吸系统疾病
心血管系统疾病
更多类别查询

图标索引 历史查询
 

acute aggravation period
相关语句
  急性加重期
     Methods The levels of sICAM-1, TNF-α and IL-8 in serum of 15 case s duri ng acute aggravation period and stable period of COPD were detected with ELISA.
     方法 采用酶联免疫吸附法 (ELISA)检测 15例COPD患者急性加重期、稳定期的sICAM - 1,TNF -α和IL - 8水平。
短句来源
     Results The sICAM-1 level in acute aggravation period of COPD was obviously high er than that in stable period (P<0.05).
     结果 COPD患者急性加重期血清sICAM- 1水平明显高于稳定期 (P <0 .0 5 )。
短句来源
     Objective It is to discuss the changes of soluble in tercellular adhesi on molecule-1 (sICAM-1), tumor necrosis factor-α(TNF-α) and interleukin-8 (IL- 8) in serum during acute aggravation period and stable period of chronic obstruc tive pulmonary disease (COPD), and to realize the net adjustive relation among t he three that in COPD attack.
     目的 探讨慢性阻塞性肺疾病 (COPD)急性加重期和稳定期血清中可溶性细胞间黏附分子 (sICAM - 1)、肿瘤坏死因子 (TNF -α)和白细胞介素 - 8(IL - 8)表达的变化 ,以了解三者在COPD发病中的网络调节关系。
短句来源
     Clinical study of integrated chinese traditional and western medicine for treating acute aggravation period of chronic cor pulmonale in 76 cases
     中西医结合治疗慢性肺原性心脏病急性加重期76例临床研究
短句来源
     Conclusions Mucosolvan can improve the clinic effect of acute aggravation period of Chronic Pulmonary Heart Disease.
     结论沐舒坦能提高慢性肺源性心脏病急性加重期的疗效,改善预后。
短句来源
更多       
  相似匹配句对
     suis. In the acute period,E.
     suis的主要形态,体形较大的E.
短句来源
     Nursing of the Acute Period of Children's Asthma
     小儿支气管哮喘急性发作治疗的护理配合
短句来源
     Clinic Therapeutic Effect of Mucosolvan Treat Acute Aggravation Period of Chronic Pulmonary Heart Disease
     沐舒坦佐治慢性肺源性心脏病急性加重期的临床疗效观察
短句来源
     Conclusions Mucosolvan can improve the clinic effect of acute aggravation period of Chronic Pulmonary Heart Disease.
     结论沐舒坦能提高慢性肺源性心脏病急性加重期的疗效,改善预后。
短句来源
     Objective To evaluate the clinic effect of using Mucosolvan on the treatment of acute aggravation period of Chronic Pulmonary Heart Disease.
     目的探讨沐舒坦佐治慢性肺源性心脏病急性加重期的临床疗效。
短句来源
查询“acute aggravation period”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
没有找到相关例句


Objective:To observe the effect of integrated chinese traditional and western medicine for treating acute aggravation period of chronic cor pulmonale.Methods:76 cases with acute aggravation period of chronic cor pulmonale were divided into treatment and control group,with 38 cases in each group.The patients in both groups were treated with the complex therapy of western medicine.On this basis of routine treatment,the patients in the treatment group were added chinese herbs.The clinical effect,arterial...

Objective:To observe the effect of integrated chinese traditional and western medicine for treating acute aggravation period of chronic cor pulmonale.Methods:76 cases with acute aggravation period of chronic cor pulmonale were divided into treatment and control group,with 38 cases in each group.The patients in both groups were treated with the complex therapy of western medicine.On this basis of routine treatment,the patients in the treatment group were added chinese herbs.The clinical effect,arterial blood gas and hemorrheological parameters of the two groups were compared by statistical approach.Results:The improvement of arterial blood gas and hemorrheological parameters in the treatment group was obvious comparing with those in the control group,with significant difference between two groups(P<0 05).Conclusion:Integrated chinese traditional and western medicine for treating acute aggravation period of chronic cor pulmonale has obvious clinical effect,and is worth clinical application.

目的 :观察中西医结合治疗慢性肺原性心脏病急性加重期的临床疗效。方法 :把慢性肺原性心脏病急性加重期患者76例 ,随机分为治疗组和对照组各38例 ,两组均按西医常规综合治疗 ,治疗组在常规治疗基础上加用中药 ,并对两组患者临床疗效、动脉血气、血液流变学指标进行对比分析。结果 :治疗组动脉血气、血液流变学指标均有明显改善 ,与对照组比较差异有显著性 ,P<0 05。结论 :中西医结合治疗慢性肺原性心脏病急性加重期具有显著临床疗效 ,值得在临床上推广应用

Objective It is to discuss the changes of soluble in tercellular adhesi on molecule-1 (sICAM-1), tumor necrosis factor-α(TNF-α) and interleukin-8 (IL- 8) in serum during acute aggravation period and stable period of chronic obstruc tive pulmonary disease (COPD), and to realize the net adjustive relation among t he three that in COPD attack.Methods The levels of sICAM-1, TNF-α and IL-8 in serum of 15 case s duri ng acute aggravation period and stable period of COPD were detected with ELISA.Results...

Objective It is to discuss the changes of soluble in tercellular adhesi on molecule-1 (sICAM-1), tumor necrosis factor-α(TNF-α) and interleukin-8 (IL- 8) in serum during acute aggravation period and stable period of chronic obstruc tive pulmonary disease (COPD), and to realize the net adjustive relation among t he three that in COPD attack.Methods The levels of sICAM-1, TNF-α and IL-8 in serum of 15 case s duri ng acute aggravation period and stable period of COPD were detected with ELISA.Results The sICAM-1 level in acute aggravation period of COPD was obviously high er than that in stable period (P<0.05). There was no obvious difference at t he T NF-α and IL-8 level between the two periods. There was no obvious relation amon g their levels in the two periods.Conclusion The sICAM-1 level in acute aggravation period of COPD h eightened refl ects the increase of the leucocyte adhesive function induced by sICAM-1 during t he disease course. That may be a new way to treat COPD.

目的 探讨慢性阻塞性肺疾病 (COPD)急性加重期和稳定期血清中可溶性细胞间黏附分子 (sICAM - 1)、肿瘤坏死因子 (TNF -α)和白细胞介素 - 8(IL - 8)表达的变化 ,以了解三者在COPD发病中的网络调节关系。方法 采用酶联免疫吸附法 (ELISA)检测 15例COPD患者急性加重期、稳定期的sICAM - 1,TNF -α和IL - 8水平。结果 COPD患者急性加重期血清sICAM- 1水平明显高于稳定期 (P <0 .0 5 )。急性加重期与稳定期血清TNF -α ,IL - 8水平无明显统计学差异 ,治疗前后各分子水平变化之间无明显相关性。结论 COPD患者急性加重期血清sICAM - 1水平的增高 ,反映了疾病过程中sICAM - 1所介导的白细胞黏附活动增加 ,可作为一个新的治疗方向。

Objective To evaluate the clinic effect of using Mucosolvan on the treatment of acute aggravation period of Chronic Pulmonary Heart Disease. Methods Randomly divide 132 cases of Chronic Pulmonary Heart Disease into two groups: control group(66 cases) and treatment group(66 cases). To Evaluate their clinic effect after 7~ 10d therapy. Results the Clinic effect of treatment group is superior to control group, the difference is significant(p<0.05). Conclusions Mucosolvan can improve the clinic effect of acute...

Objective To evaluate the clinic effect of using Mucosolvan on the treatment of acute aggravation period of Chronic Pulmonary Heart Disease. Methods Randomly divide 132 cases of Chronic Pulmonary Heart Disease into two groups: control group(66 cases) and treatment group(66 cases). To Evaluate their clinic effect after 7~ 10d therapy. Results the Clinic effect of treatment group is superior to control group, the difference is significant(p<0.05). Conclusions Mucosolvan can improve the clinic effect of acute aggravation period of Chronic Pulmonary Heart Disease.

目的探讨沐舒坦佐治慢性肺源性心脏病急性加重期的临床疗效。方法132例患者随机分为治疗组与对照组,对照组采用常规治疗,治疗组在常规治疗基础上加用沐舒坦治疗,7~10天后对比两组的治疗效果。结果治疗组与对照组的有效率分别为83.33%、65.15%,入住RICU的机率分别为7.58%、22.73%,两者比较差异有显著性。结论沐舒坦能提高慢性肺源性心脏病急性加重期的疗效,改善预后。

 
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关acute aggravation period的内容
在知识搜索中查有关acute aggravation period的内容
在数字搜索中查有关acute aggravation period的内容
在概念知识元中查有关acute aggravation period的内容
在学术趋势中查有关acute aggravation period的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社